Mylasia waxay ansixisay SARS-CoV-2 antigen xirmada tijaabinta degdega ah ee iskiis
Mylasia waxay ansixisay SARS-CoV-2 antigen xirmada tijaabinta degdega ah ee iskiis
Tilmaamaha Isticmaalka
— Si loogu isticmaalo guriga
is-imtixaan ama mid aan xirfad lahayn
-Si loogu isticmaalo dalool sanka (sanka hore) shaybaarka suufka
— Loogu talagalay Isticmaalka Cilad-sheegidda Gudaha ee Vitro Kaliya
Kaydinta
Xirmada tijaabada waa in lagu kaydiyaa heerkulka 2°C ~ 30°C, qalalan oo aan qorraxdu toos ahayn (ha xidhin xidhmada ama qaybaha ka kooban yahay).
Nolosha shelf ee xirmada waa 12 bilood.
Kaarka tijaabada ah waa in lagu isticmaalo 60 daqiiqo gudahood ka dib marka la furo bacda aluminiumka.
Taariikhda uu dhacayo xirmada, fadlan tixraac calaamadda alaabta.
Dareenka: 98.26% (95% CI 93.86% ~ 99.79%)
Gaar ahaan: 100.00% (95% CI 99.19% ~ 100.00%)
Qiimaha Saadaasha Wanaagsan: 100% (95% CI 96.79% ~ 100.00%)
Qiimaha Saadaasha Xun:99.56%(95%CI 98.43%~99.95%)
Guud ahaan Heshiska Boqolkiiba:99.65%(95%CI 98.74~99.96%)
Imtixaanka degdega ah ee SARS-CoV-2 Antigen-ka waxaa loogu talagalay in lagu ogaado tayada SARS-CoV-2 Antigen ee swab oropharyngea iyo muunado swab nasopharyngeal gudaha Vitro